Medpace Holdings, Inc. — Director's Dealing 2021

Apr 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-04-14

Reporting Person: EWALD STEPHEN P (General Counsel & Corp. Secy.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-14	Common Stock	M	1200	$28.32	Acquired	15054	Direct
2021-04-14	Common Stock	S	1200	$180.67	Disposed	13854	Direct
2021-04-15	Common Stock	M	3800	$28.32	Acquired	17654	Direct
2021-04-15	Common Stock	S	3800	$185.18	Disposed	13854	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-14	Employee Stock Option (Right to Buy)	$28.32	M	1200	Disposed	2024-03-15	Common Stock (1200)	Direct
2021-04-15	Employee Stock Option (Right to Buy)	$28.32	M	3800	Disposed	2024-03-15	Common Stock (3800)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.11 to $181.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.13 to $187.07. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F4: Each option vested on March 15, 2021.